Arrowhead Pharmaceuticals, Inc. Stock Forecast

Weaker technical forecast for Arrowhead Pharmaceuticals, Inc. as stock downgraded to Hold/Accumulate.
(Updated on Jun 28, 2024)

0HI3.L Signals & Forecast

The Arrowhead Pharmaceuticals, Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $25.85. On a fall, the stock will find some support from the long-term average at approximately $24.69. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, June 24, 2024, and so far it has fallen -9.48%. Further fall is indicated until a new bottom pivot has been found. Arrowhead Pharmaceuticals, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Arrowhead Pharmaceuticals, Inc. stock

Arrowhead Pharmaceuticals, Inc. finds support from accumulated volume at $24.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.305 between high and low, or 1.22%. For the last week, the stock has had daily average volatility of 3.19%.

Our recommended stop-loss: $23.84 (-4.88%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 31 days ago.)

Trading Expectations (0HI3.L) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Arrowhead Pharmaceuticals, Inc. to open at $25.17, and during the day (based on 14 day Average True Range), to move between $23.97 and $26.16, which gives a possible trading interval of +/-$1.10 (+/-4.39%) up or down from last closing price. If Arrowhead Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 8.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $26.00 (3.73%) than the support at $24.03 (4.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Arrowhead Pharmaceuticals, Inc. stock A Buy?

Arrowhead Pharmaceuticals, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Arrowhead Pharmaceuticals, Inc. of Monday, July 1, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.